Ram Waisbourd, See Remarks at 89bio, Inc. (ETNB), sold 7,000 shares at $5.70 ($40K) on 2022-02-01, disclosed to the SEC on 2022-02-03.
Scheduled sale ($40k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ETNB | SELL | 2021-10-20 | $245K | — | Filing → |
| ETNB | SELL | 2021-09-20 | $136K | — | Filing → |
| ETNB | SELL | 2021-08-18 | $256K | — | Filing → |